https://geneonline.news/處方藥轉非處方藥挑戰與機遇解析/2026-02-04T19:58:01.000Zweekly0.8 https://geneonline.news/阿斯利康免疫治療新方案獲印度批准提升胃癌治療/2026-02-04T19:57:52.000Zweekly0.8 https://geneonline.news/印度製藥巨頭推出-dasatinib-學名藥挑戰原廠市場地位/2026-02-04T19:57:42.000Zweekly0.8 https://geneonline.news/印度批准durvalumab聯合flot方案用於可切除胃癌治療-2/2026-02-04T19:57:33.000Zweekly0.8 https://geneonline.news/遠距醫療支付處理與合規性挑戰加劇-展望2026年解決/2026-02-04T19:56:59.000Zweekly0.8 https://geneonline.news/藥品批發商效仿pbm模式推動垂直整合引發市場關注/2026-02-04T19:56:15.000Zweekly0.8 https://geneonline.news/疫情後醫療診斷差距持續存在揭示健康不平等問題/2026-02-04T19:56:04.000Zweekly0.8 https://geneonline.news/susan-g-komen-發布乳癌進展報告-聚焦研究與患者支持/2026-02-04T19:55:55.000Zweekly0.8 https://geneonline.news/奈米技術結合噬菌體療法-有望破解抗藥性細菌感染/2026-02-04T19:55:09.000Zweekly0.8 https://geneonline.news/人工合成humanin胜肽可顯著提升公牛繁殖力與精液品質/2026-02-04T19:54:59.000Zweekly0.8 https://geneonline.news/化學策略提升礦物質生物利用率助力改善營養狀況/2026-02-04T19:54:51.000Zweekly0.8 https://geneonline.news/高科技成像技術助力亞伯達省林業可持續發展-3/2026-02-04T19:54:33.000Zweekly0.8 https://geneonline.news/虛擬圍欄技術興起-革新畜牧業管理模式/2026-02-04T19:54:24.000Zweekly0.8 https://geneonline.news/羅氏攜手中國-sangenebio-投資-17-億美元共研-rnai-創新療法/2026-02-04T19:54:14.000Zweekly0.8 https://geneonline.news/2021-年生技-ipo-熱潮三年後現況分析-挑戰與機遇並存/2026-02-04T19:54:05.000Zweekly0.8 https://geneonline.news/罕見疾病藥物開發進入加速成長關鍵時代/2026-02-04T19:53:55.000Zweekly0.8 https://geneonline.news/輝瑞metsera平台與生技醫藥產業創新挑戰分析/2026-02-04T19:53:45.000Zweekly0.8 https://geneonline.news/fda-推動對接受-car-t-療法治療自體免疫疾病患者進行長期/2026-02-04T19:53:33.000Zweekly0.8 https://geneonline.news/fda局長回應優先審查憑證計畫爭議-強調不影響審查/2026-02-04T19:53:13.000Zweekly0.8 https://geneonline.news/減重對預防常見疾病的重要性與健康效益分析/2026-02-04T19:51:50.000Zweekly0.8 https://geneonline.news/研究揭示非腦部疾病與失智症風險密切相關/2026-02-04T19:51:43.000Zweekly0.8 https://geneonline.news/人工智慧工具突破蛋白質結構預測難題推動生物醫/2026-02-04T18:59:32.000Zweekly0.8 https://geneonline.news/美國國會推動改革藥品福利管理機構以降低處方藥/2026-02-04T18:59:21.000Zweekly0.8 https://geneonline.news/全球藥品可及性挑戰與解決策略分析/2026-02-04T18:59:10.000Zweekly0.8 https://geneonline.news/製藥品牌突破專利懸崖成功逆轉市場生命週期/2026-02-04T18:59:00.000Zweekly0.8 https://geneonline.news/人工智慧加速製藥產業發展但人為監督仍不可或缺/2026-02-04T18:58:50.000Zweekly0.8 https://geneonline.news/orbis-收購-robinson-industries-擴大可重複使用包裝市場影響力-2/2026-02-04T18:58:41.000Zweekly0.8 https://geneonline.news/阿斯利康美國市場受挫與歐洲藥品審批挑戰解析/2026-02-04T18:58:33.000Zweekly0.8 https://geneonline.news/毛細管電泳技術助力無尾mrna精準檢測及應用前景探/2026-02-04T18:58:23.000Zweekly0.8 https://geneonline.news/標準推動生醫產業邁向永續發展挑戰與機遇並存/2026-02-04T18:58:10.000Zweekly0.8 https://geneonline.news/必治妥施貴寶與嬌生競逐免疫療法市場-領先地位爭/2026-02-04T18:58:01.000Zweekly0.8 https://geneonline.news/cellares-推動-idmo-模式加速基因編輯幹細胞療法商業化進程/2026-02-04T18:57:52.000Zweekly0.8 https://geneonline.news/血清肌酸酐與胱抑素c比值可成為髖部骨折風險新指/2026-02-04T18:57:43.000Zweekly0.8 https://geneonline.news/馬拉威基層醫療績效管理面臨挑戰與改進方向探討/2026-02-04T18:57:32.000Zweekly0.8 https://geneonline.news/美國議員質疑fda優先審查憑證計畫合法性引發廣泛/2026-02-04T18:57:23.000Zweekly0.8 https://geneonline.news/aquestive-therapeutics-新藥-anaphylm-收到-fda-完全回應函-無法批准上市/2026-02-04T18:57:16.000Zweekly0.8 https://geneonline.news/毛細管電泳技術突破無尾-mrna-檢測瓶頸-2/2026-02-04T18:56:58.000Zweekly0.8 https://geneonline.news/標準助力生醫產業邁向永續發展/2026-02-04T18:56:45.000Zweekly0.8 https://geneonline.news/免疫療法市場專利爭議升溫-必治妥施貴寶與嬌生面/2026-02-04T18:56:34.000Zweekly0.8 https://geneonline.news/cellares-推動基因編輯幹細胞療法製造革新-加速臨床應用/2026-02-04T18:56:26.000Zweekly0.8 https://geneonline.news/fda-對-anaphylm-提出擔憂-aquestive-therapeutics-面臨挑戰/2026-02-04T18:56:17.000Zweekly0.8 https://geneonline.news/處方藥轉非處方藥引發商業模式變革-藥廠需全面調/2026-02-04T18:55:59.000Zweekly0.8 https://geneonline.news/阿斯利康免疫治療藥物獲印度批准用於胃癌治療/2026-02-04T18:55:49.000Zweekly0.8 https://geneonline.news/印度製藥巨頭-lupin-推出-dasatinib-學名藥-為美國白血病患者-2/2026-02-04T18:55:38.000Zweekly0.8 https://geneonline.news/印度批准durvalumab聯合flot方案治療可切除胃癌與胃食管交/2026-02-04T18:55:28.000Zweekly0.8 https://geneonline.news/sun-pharma-成為皇家挑戰者班加羅爾隊首席贊助商及健康合/2026-02-04T18:55:19.000Zweekly0.8 https://geneonline.news/fda推出precheck計畫-助力藥品研發加速上市/2026-02-04T18:55:07.000Zweekly0.8 https://geneonline.news/藥廠轉型成功案例：擴大適應症與市場滲透助力銷/2026-02-04T18:55:01.000Zweekly0.8 https://geneonline.news/遠距醫療支付模式與合規性挑戰展望2026年發展趨勢-3/2026-02-04T18:54:49.000Zweekly0.8 https://geneonline.news/藥品批發商效法pbm模式推動垂直整合改變市場格局/2026-02-04T18:54:40.000Zweekly0.8 https://geneonline.news/新冠疫情後遺症：憂鬱症與慢性疾病診斷缺口引發/2026-02-04T18:54:31.000Zweekly0.8 https://geneonline.news/牛血清蛋白奈米粒子提升噬菌體穩定性與抗菌活性-2/2026-02-04T18:54:20.000Zweekly0.8 https://geneonline.news/研究顯示-humanin-可顯著提升公牛精液品質與繁殖效率/2026-02-04T18:54:11.000Zweekly0.8 https://geneonline.news/羅氏與-sangenebio-簽署-17-億美元合作協議-加速-rnai-療法開發/2026-02-04T18:54:02.000Zweekly0.8 https://geneonline.news/2021年生技ipo熱潮退燒-市場回歸理性挑戰與機遇並存/2026-02-04T18:53:53.000Zweekly0.8 https://geneonline.news/罕見疾病藥物開發進入加速時代-挑戰與機遇並存/2026-02-04T18:53:43.000Zweekly0.8 https://geneonline.news/肥胖與減重對健康的影響及未來研究方向/2026-02-04T18:53:23.000Zweekly0.8 https://geneonline.news/浩鼎-4174-本公司接獲美國西南腫瘤集團通知，關於/2026-02-04T18:09:54.000Zweekly0.8 https://geneonline.news/輝瑞面臨新冠紅利消退挑戰-積極佈局多元化成長策/2026-02-04T17:54:45.000Zweekly0.8 https://geneonline.news/印度批准durvalumab聯合flot方案用於可切除胃癌治療/2026-02-04T17:54:37.000Zweekly0.8 https://geneonline.news/不寧腿症候群患者分享長期用藥副作用引發治療策/2026-02-04T17:52:05.000Zweekly0.8 https://geneonline.news/川普政府干預fda審查迷幻藥療法引發科學與政治爭/2026-02-04T17:51:57.000Zweekly0.8 https://geneonline.news/新晉科學家如何在延續與創新間找到平衡建立獨特/2026-02-04T17:51:49.000Zweekly0.8 https://geneonline.news/科懋-6496-公告本公司114年度財務報告董事會召開日期/2026-02-04T17:24:54.000Zweekly0.8 https://geneonline.news/msd-2025-financial-results-2026-026news/2026-02-23T16:26:40.000Zweekly0.8 https://geneonline.news/台達電-2308-補充公告本公司代子公司delta-electronics-usa-inc-公告決/2026-02-04T17:14:54.000Zweekly0.8 https://geneonline.news/誘導契合生長技術推動鎵半導體類神經裝置應用發/2026-02-04T16:55:56.000Zweekly0.8 https://geneonline.news/慕康生醫-5398-公告本公司董事會決議不分派股利/2026-02-04T16:54:53.000Zweekly0.8 https://geneonline.news/罕見疾病藥物開發迎來挑戰與機遇轉折點/2026-02-04T16:53:36.000Zweekly0.8 https://geneonline.news/慕康生醫-5398-公告本公司董事會決議召開115年股東常/2026-02-04T16:44:54.000Zweekly0.8 https://geneonline.news/霈方-6574-公告本公司最近一年累積取得有價證券達/2026-02-04T16:19:53.000Zweekly0.8 https://geneonline.news/慕康生醫-5398-代重要子公司聯崴生技股公司盈餘轉/2026-02-04T16:14:55.000Zweekly0.8 https://geneonline.news/益得-6461-本公司董事會通過簽訂獨家授權經銷協議/2026-02-04T16:14:54.000Zweekly0.8 https://geneonline.news/慕康生醫-5398-公告本公司董事會決議辦理私募有價/2026-02-04T16:14:53.000Zweekly0.8 https://geneonline.news/慕康生醫-5398-公告本公司董事會通過114年度合併財務/2026-02-04T16:09:53.000Zweekly0.8 https://geneonline.news/美國國會通過法案維持-nih-高位經費並增加特定研究/2026-02-04T15:55:31.000Zweekly0.8 https://geneonline.news/輝瑞面臨減肥藥挑戰但多元產品線助力未來增長/2026-02-04T15:55:21.000Zweekly0.8 https://geneonline.news/美國眾議員質疑fda國家優先審查憑證計畫合法性引/2026-02-04T15:55:11.000Zweekly0.8 https://geneonline.news/台達電-2308-本公司自辦法人說明會之相關資訊/2026-02-04T15:54:53.000Zweekly0.8 https://geneonline.news/精確-3162-代子公司東台精玖旺硬質合金科技有限公-2/2026-02-04T15:09:59.000Zweekly0.8 https://geneonline.news/精確-3162-代子公司湖北精確新能源科技有限公司依/2026-02-04T15:09:57.000Zweekly0.8 https://geneonline.news/精確-3162-代子公司東台精玖旺硬質合金科技有限公/2026-02-04T15:09:56.000Zweekly0.8 https://geneonline.news/博士旺-3555-本公司有價證券近期多次達公布注意交/2026-02-04T15:09:55.000Zweekly0.8 https://geneonline.news/精確-3162-本公司依公開發行公司資金貸與及背書保/2026-02-04T15:09:53.000Zweekly0.8 https://geneonline.news/腎臟都卜勒超音波在兒童腎病症候群中的應用潛力/2026-02-04T14:56:48.000Zweekly0.8 https://geneonline.news/瑞士推動超高性能纖維混凝土應用-打造永續橋樑建/2026-02-04T14:56:36.000Zweekly0.8 https://geneonline.news/基因組堆疊揭示雜種優勢新機制-推動農業育種創新/2026-02-04T14:56:26.000Zweekly0.8 https://geneonline.news/韓國化學技術研究院突破垃圾掩埋氣體轉化永續航/2026-02-04T14:56:16.000Zweekly0.8 https://geneonline.news/處方藥轉非處方藥掀商業模式變革-藥廠面臨全面挑/2026-02-04T14:56:06.000Zweekly0.8 https://geneonline.news/阿斯利康durvalumab聯合flot方案獲印度批准用於可切除胃癌/2026-02-04T14:55:54.000Zweekly0.8 https://geneonline.news/印度製藥巨頭lupin推出達沙替尼學名藥挑戰美國市場/2026-02-04T14:55:43.000Zweekly0.8 https://geneonline.news/遠距醫療面臨支付模式多元化與合規性挑戰/2026-02-04T14:55:25.000Zweekly0.8 https://geneonline.news/藥品批發商效仿pbm策略推動垂直整合引發供應鏈深/2026-02-04T14:55:15.000Zweekly0.8 https://geneonline.news/新冠疫情後診斷缺口持續存在-憂鬱症與慢性疾病患/2026-02-04T14:55:06.000Zweekly0.8 https://geneonline.news/研究發現粒線體衍生胜肽-humanin-可顯著提升公牛精液品/2026-02-04T14:54:34.000Zweekly0.8 https://geneonline.news/羅氏與sangenebio合作加速rnai療法開發布局/2026-02-04T14:54:25.000Zweekly0.8 https://geneonline.news/2021年生技ipo熱潮後的現況與挑戰分析/2026-02-04T14:54:17.000Zweekly0.8 https://geneonline.news/高科技成像技術助力亞伯達省林業實現精準化管理/2026-02-04T14:53:20.000Zweekly0.8 https://geneonline.news/虛擬圍欄技術興起-革新畜牧業管理模式與環境效益/2026-02-04T14:53:10.000Zweekly0.8 https://geneonline.news/美國法官駁回針對學術出版商不當得利的集體訴訟/2026-02-04T14:52:36.000Zweekly0.8